“K2M is deeply committed to advancing care for scoliosis patients and we have developed technologies like MESA and Rail to put new capabilities into the hands of surgeons who treat the most complex spinal deformities,” said Eric Major, K2M president and CEO. “We are extremely pleased by the new indication and this milestone achievement allowing K2M to provide innovative solutions for surgeons treating pediatric patients.”
More Articles on Orthopedic Devices:
Will Medical Device Companies Benefit From Healthcare Reform?
7 Ways to Market Artificial Discs in Spine Practices
TranS1 Names Dr. Stephanie Fitts Vice President of Regulatory, Quality and Compliance
